Microencapsulation of Lefty-secreting engineered cells for pulmonary fibrosis therapy in mice.

about

Microencapsulation of Lefty-secreting engineered cells for pulmonary fibrosis therapy in mice.

Item

http://www.wikidata.org/entity/Q40329746

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Microencapsulation of Lefty-se ...... nary fibrosis therapy in mice.

@en

type

Item

label

Microencapsulation of Lefty-se ...... nary fibrosis therapy in mice.

@en

prefLabel

Microencapsulation of Lefty-se ...... nary fibrosis therapy in mice.

@en

P1476

Microencapsulation of Lefty-se ...... onary fibrosis therapy in mice

@en

P2093

Hongge Ma

http://www.w3.org/2001/XMLSchema#string

Lifen Yao

http://www.w3.org/2001/XMLSchema#string

Shuai Geng

http://www.w3.org/2001/XMLSchema#string

Shupei Qiao

http://www.w3.org/2001/XMLSchema#string

Xiaolu Hou

http://www.w3.org/2001/XMLSchema#string

Yufang Zhao

http://www.w3.org/2001/XMLSchema#string

Zeli Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis

Update on diagnosis and treatment of idiopathic pulmonary fibrosis

Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century

Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta receptor

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

Pulmonary fibrosis: pathogenesis, etiology and regulation

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study.

Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression

Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice

P304

L741-L747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPLUNG.00295.2016

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

312

http://www.w3.org/2001/XMLSchema#string

P50

Weiming Tian

Xiongbiao Chen

P577

2017-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28213468

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis